Star Sports Medicine to Convene 17 Aug Board Meeting for H1 2026 Results and Dividend Deliberation

Bulletin Express

Aug 05

Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month period ended 30 June 2026 and decide on the declaration of an interim dividend, if any.

The meeting notice was issued by Chairman and Executive Director Mr. Dong Wenxing on 5 August 2026. As of the date of the announcement, the Board comprises:

• Executive Directors: Mr. Dong Wenxing, Mr. He Lu • Non-executive Directors: Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin, Mr. Zhou Quan • Independent Non-executive Directors: Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie, Mr. Wang Chunfei

No financial metrics or dividend figures were disclosed in the notice. The company will release its interim financial report following board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1144824222"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144824222\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144824222?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 17:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144824222","market":"us","top_or_hot":-1,"title":"Star Sports Medicine to Convene 17 Aug Board Meeting for H1 2026 Results and Dividend Deliberation","media":"Bulletin Express","content":"<p>Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month period ended 30 June 2026 and decide on the declaration of an interim dividend, if any.</p>\n<p>The meeting notice was issued by Chairman and Executive Director Mr. Dong Wenxing on 5 August 2026. As of the date of the announcement, the Board comprises:</p>\n<p>• Executive Directors: Mr. Dong Wenxing, Mr. He Lu  \n• Non-executive Directors: Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin, Mr. Zhou Quan  \n• Independent Non-executive Directors: Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie, Mr. Wang Chunfei</p>\n<p>No financial metrics or dividend figures were disclosed in the notice. The company will release its interim financial report following board approval.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Star Sports Medicine to Convene 17 Aug Board Meeting for H1 2026 Results and Dividend Deliberation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStar Sports Medicine to Convene 17 Aug Board Meeting for H1 2026 Results and Dividend Deliberation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month period ended 30 June 2026 and decide on the declaration of an interim dividend, if any.</p>\n<p>The meeting notice was issued by Chairman and Executive Director Mr. Dong Wenxing on 5 August 2026. As of the date of the announcement, the Board comprises:</p>\n<p>• Executive Directors: Mr. Dong Wenxing, Mr. He Lu  \n• Non-executive Directors: Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin, Mr. Zhou Quan  \n• Independent Non-executive Directors: Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie, Mr. Wang Chunfei</p>\n<p>No financial metrics or dividend figures were disclosed in the notice. The company will release its interim financial report following board approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01609","symbol_name":"天星医疗","start_time":0,"source_url":"","article_id":"1144824222","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144824222","pubTimestamp":1785922367,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01609":"天星医疗"},"translate_title":"Star Sports Medicine 将于 8 月 17 日召开董事会会议，讨论 2026 年上半年业绩和股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1},"content_text":"Star Sports Medicine Co., Ltd. (Star Sports Medicine) has scheduled a board meeting for Monday, 17 August 2026. Directors will review and approve the unaudited interim results for the six-month period ended 30 June 2026 and decide on the declaration of an interim dividend, if any.\nThe meeting notice was issued by Chairman and Executive Director Mr. Dong Wenxing on 5 August 2026. As of the date of the announcement, the Board comprises:\n• Executive Directors: Mr. Dong Wenxing, Mr. He Lu  \n• Non-executive Directors: Ms. Zhang Di, Mr. Chang Xi, Mr. David Guowei Wang, Ms. Yi Lin, Mr. Zhou Quan  \n• Independent Non-executive Directors: Mr. Lyu Zhenlin, Mr. Deng Yu, Mr. Liu Baojie, Mr. Wang Chunfei\nNo financial metrics or dividend figures were disclosed in the notice. The company will release its interim financial report following board approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}